Glenmark receives ANDA approval for Olmesartan Medoxomil tabs

The tablets will be manufactured at its Goa facility

Glenmark Pharmaceuticals has been granted final approval by the US FDA for Olmesartan Medoxomil tablets, 5 mg, 20 mg and 40 mg. It is the generic version of Benicar Tablets, 5 mg, 20 mg and 40 mg, of Daiichi Sankyo. Glenmark’s Olmesartan Medoxomil tablets will be manufactured by Glenmark Pharmaceuticals in its manufacturing facility located in Goa.